| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,673,000 | 1,995,000 | 2,981,000 | 7,492,000 | | Cost of Revenue | 260,000 | 278,000 | 270,000 | 276,000 | | | Gross Profit | 1,413,000 | 1,717,000 | 2,711,000 | 7,216,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 597,000 | 636,000 | 764,000 | 1,210,000 | | Non Recurring | 39,000 | 9,630,000 | 2,830,000 |
-
| | Others | 353,000 | 504,000 | 504,000 | 528,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 424,000 | (9,053,000) | (1,387,000) | 5,478,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (66,000) | (93,000) | 100,000 | (47,000) | | Earnings Before Interest And Taxes | 358,000 | (9,146,000) | (1,287,000) | 5,431,000 | | Interest Expense | (30,000) | 38,000 | 102,000 | 45,000 | | Income Before Tax | 388,000 | (9,184,000) | (1,389,000) | 5,386,000 | | Income Tax Expense | 146,000 | (3,444,000) | (528,000) | 2,073,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 242,000 | (5,740,000) | (861,000) | 3,313,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 242,000 | (5,740,000) | (861,000) | 3,313,000 | | Preferred Stock And Other Adjustments | (6,000) | (6,000) | (6,000) | (31,000) | | | Net Income Applicable To Common Shares | $236,000 | ($5,746,000) | ($867,000) | $3,282,000 |
|
2.03% Nasdaq 
Income Statement
